-
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
-
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
-
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
-
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
RBI Data Reveals Divergence in Credit Card Spending and Debit Card Cash Withdrawals
-
First-time boat buyers advised to assess full ownership costs
-
Panthers expected to begin 2027 NRL season away from new stadium
-
Planning and preparation can reduce stress of interstate relocation
-
Sweet As app launches restaurant discovery platform
-
Two more arrested in Carrie Mullane suspected murder investigation
-
Phoenix Restaurants Offer Thanksgiving Dinner to Go for Pickup
-
MLA seeks inquiry into reported sectarian gestures on Ormeau Road
-
Mayo school appeals for information after convent and chapel vandalism
-
Louise O’Reilly attacks Simon Harris over unemployment remarks
-
Virginia overwhelms Arkansas 91-72 behind balanced scoring
-
Canadian soldier Aidan Goulding remembered at Vancouver funeral
-
Second major storm brings destructive winds and outages to British Columbia
-
Tayyab Arif hits 57 on Pakistan Test debut against Sri Lanka
-
Godzilla Minus Zero leads North American box office with $31.6m
-
Robert Trujillo discusses literacy and social justice children’s books
-
Advocate calls for coordinated support for children facing trafficking
-
Civil rights advocate William Bill Tucker dies aged 98
-
Medicare Open Enrollment Ends Dec. 7: Review Your Coverage Options
-
Pennsylvania Democrats secure state trifecta in midterm elections
-
US Treasury order targets bank transfers linked to crypto exchange MEXC
-
Godzilla Minus Zero sets foreign-language box-office opening record
-
Nvidia CEO Controversy Sparks Fears of Tighter U.S. AI Chip Curbs for Samsung and SK hynix
-
Eagles record six sacks as rushing attack struggles against Giants
-
Villeneuve teases James Bond casting at Los Angeles museum gala
-
Thames Water seeks to delay £12bn in debt repayments
-
Nottinghamshire launches specialist rural crime policing team
-
Newark boxing gym expands alternative education programme
-
China confirms talks over possible Xi-Putin-Trump summit
-
Democrats consider impeachment drive against Defence Secretary Hegseth
-
Rail journey offers a slower route to a Berlin city break
-
Energy bill plan could use HMRC income data to target support
-
Arsenal control title race as Manchester United fall into bottom three
-
Business owner earning £6,000 a month tackles £70,000 debt
-
Suspected Krakow gunman dies after attack that killed six
-
Nvidia chief faces inquiry after disclosing affair with suspected Chinese agent
-
Carrick backs Dalot after hostile reception from Manchester United fans
-
Comet returns as online electrical marketplace 14 years after collapse
CBDL Announces Strategic Rollout on Vibe Performance Network, Elevating 8000MG Pain Cream to National Streaming Audiences
CBD Life Sciences Inc. (OTC:CBDL) expands its digital advertising arsenal through the Vibe Performance Network, positioning its flagship 8000MG Pain Cream in front of millions of engaged, wellness-focused viewers - unlocking massive revenue potential and long-term shareholder value in the booming CBD market.
SCOTTSDALE, ARIZONA / ACCESS Newswire / July 8, 2025 / CBD Life Sciences Inc. (OTC:CBDL), parent company of CBD Vault, is thrilled to announce a transformational leap in its national marketing strategy through integration with Vibe, a cutting-edge self-serve streaming TV advertising platform. This strategic move empowers CBDL to deliver targeted, data-driven campaigns across top-tier streaming platforms including Hulu, ESPN+, Roku, Discovery+, Tubi, and dozens of other premium outlets.
As part of this rollout, CBDL will begin aggressively marketing its new 8000MG Pain Relief Cream - its most potent and in-demand product to date. Designed for athletes, chronic pain sufferers, and everyday individuals seeking fast, long-lasting relief, the 8000MG Pain Cream delivers unparalleled results - and now, it will reach a national audience with unmatched precision.
"This initiative represents one of the most important and scalable steps forward in CBDL's history," said Lisa Nelson, President & CEO of CBDL. "With Vibe, we're not just buying ad space - we're owning the channel to our core audience. This technology allows us to place the right product in front of the right person at the right time. That means greater efficiency, greater visibility, and greater returns."
The Vibe Advantage: Why This is a Major Inflection Point for CBDL
CBDL's integration with the Vibe Performance Network gives the company unprecedented access to millions of health-conscious consumers across the U.S., including targeted audiences based on:
Demographics (age, gender, income)
Behavioral habits and content interests
Zip-code level geographic targeting
Engagement with wellness, recovery, fitness, and CBD-related content
Unlike traditional TV or social media ads, Vibe campaigns are performance-optimized - allowing for real-time analytics, creative testing, and dynamic budget scaling, all while keeping advertising costs significantly lower than legacy platforms.
Projected Revenue Impact and Market Positioning
With this expanded visibility, CBDL is now positioned to unlock significant recurring revenue across both direct-to-consumer and wholesale channels. Based on historical customer conversion data and industry benchmarks, the 8000MG Pain Cream campaign alone could drive a projected 7-figure boost in annual revenue, with the potential to scale beyond as CBD Vault's product line continues to grow.
This launch directly supports the company's mission of becoming a nationally recognized leader in natural wellness solutions, while laying the groundwork for future product launches using the same Vibe infrastructure.
The global CBD market is forecasted to exceed $22 billion by 2030, and topical CBD products - like pain creams - are expected to see the highest CAGR within the industry at over 32.1% annually, according to Grand View Research.
CBDL's powerful combination of product efficacy, consumer trust, and now digital ad precision, gives the company a major competitive edge as it scales nationwide.
Investor Significance
For current and prospective investors, this strategic deployment represents a material turning point in how the company markets, sells, and scales. By implementing a scalable, intelligent advertising ecosystem, CBDL is no longer reliant on outdated, inefficient marketing tactics - instead embracing the same programmatic tools used by Fortune 500 brands, tailored for the cannabis and wellness space.
In essence, CBDL now controls its own national media pipeline, giving the company the ability to:
Increase customer acquisition at lower costs
Expand brand awareness across multiple demographics
Support higher margins and longer customer lifetime value
Launch future products into an already-primed national audience
"This is more than just a campaign - it's infrastructure," added Nelson. "It's a system that can be used again and again to take new products to market, drive sales, and fuel consistent growth. It's a future-proof marketing engine."
Vibe Platform Website : https://www.vibe.co/

About CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc. is an innovative health and wellness company committed to the research, development, and distribution of premium cannabidiol (CBD) products through its core brand, CBD Vault. From topicals and tinctures to wellness beverages and skincare solutions, CBDL is building a portfolio of products designed for maximum efficacy, transparency, and consumer trust.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: [email protected]
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
[email protected]
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original press release on ACCESS Newswire
P.Costa--AMWN